n,n-dimethylarginine has been researched along with Antiphospholipid Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belizna, C; Djokovic, A; Dopsaj, V; Marisavljevic, D; Markovic, O; Saponjski, D; Saponjski, J; Stanisavljevic, N; Stojanovich, L; Todic, B; Zdravkovic, M | 1 |
| Cervar-Zivkovic, M; Eberhard, K; Kolovetsiou-Kreiner, V; Lang, U; Mayer-Pickel, K; Mörtl, MG; Obermayer-Pietsch, B; Schlembach, D | 1 |
2 other study(ies) available for n,n-dimethylarginine and Antiphospholipid Syndrome
| Article | Year |
|---|---|
Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients.
Topics: Antiphospholipid Syndrome; Arginine; Biomarkers; C-Reactive Protein; Dilatation, Pathologic; Endothelium, Vascular; Humans; Nitroglycerin; Thrombosis; Vasodilation | 2022 |
Endothelin 1, ADMA and SDMA in pregnancies with obstetric and thrombotic antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Arginine; Chronic Disease; Endothelin-1; Endothelium, Vascular; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Prognosis; Thrombosis; Young Adult | 2016 |